AI臨床試驗模擬器
QuantHealth 為其臨床試驗模擬平台籌得4500萬美元
QuantHealth 完成 4,500 萬美元 B 輪融資，擴展其以人工智能驅動的臨床試驗模擬平台，協助藥廠及生物科技公司在招募病人前測試並優化研究設計。是次融資由 Qumra Capital 領投，Sanofi Ventures 及多家專注醫療保健的投資機構參與其中。
該平台讓試驗團隊能模擬不同的患者群體、治療組及對照組、終點指標及試驗方案參數，在投入資金前評估潛在結果。QuantHealth 計劃將資金用於開發新一代人工智能模型、擴展其數據集及治療領域至逾 40 個適應症，並加強其技術的科學驗證。
對藥物開發商而言，這種方法有助更早識別試驗風險，並改善整體臨床開發規劃。是次融資反映業界對以人工智能驅動的模擬工具日益增加的投資，旨在支持更明智的試驗設計及開發決策。
英文原文
QuantHealth raised $45 million in Series B funding to expand its AI-powered clinical trial simulation platform, which helps pharmaceutical and biotechnology companies test and optimize study designs before enrolling patients. The round was led by Qumra Capital, with participation from Sanofi Ventures and several other healthcare-focused investors.
The platform allows trial teams to simulate different patient populations, treatment and control arms, endpoints and protocol parameters to evaluate potential outcomes before committing capital. QuantHealth plans to use the funding to develop next-generation AI models, expand its datasets and therapeutic coverage to more than 40 indications, and increase scientific validation of its technology.
For drug developers, the approach can help identify trial risks earlier and improve planning across clinical development. The funding reflects growing investment in AI-based simulation tools designed to support more informed trial design and development decisions.
- 來源
- Trend Hunter
- 發布
- 2026-08-14
- 品類
- Ai
- 出處
- mobihealthnews